Spray drying technology makes it possible to create advanced protein/peptide biologics, such as high-concentration protein/peptide suspensions, protein/peptide pulmonary inhalation formulations, and protein/peptide implants. With the most advanced spray drying technology, CD Formulation has extensive experience in processing a variety of biologics, including monoclonal antibodies, recombinant proteins, therapeutic peptides, etc., to support your protein/peptide biologics spray drying formulation development and particle design, improving product stability and seamlessly integrate into advanced drug delivery systems.
The physicochemical instability of proteins and peptides during processing and storage is a major obstacle to their drug development and application. Protein/peptide biologics are usually prepared in solid dosage forms because higher stability can be achieved in a solid than in a liquid state.
Spray drying technology is one of the most common methods to increase the stability of proteins and peptides. This technology is a faster and more economical single-step drying method that can be designed as a continuous drying process. It can control the particle size and morphology of the dried powder by changing process parameters and formulation factors. In addition, the application of nano spray dryers can also produce nano-scale powders, improve the stability and therapeutic potential of proteins/peptides, and make them more effective and less toxic.
Successful development of protein/peptide spray-dried formulations requires overcoming the challenges of the spray-drying process on protein/peptide stability. A stable protein/peptide formulation should have low water content (protein stability is inversely proportional to water activity), be able to be reconstituted quickly (rapid and complete reconstitution is usually achieved through a larger powder surface area), and have an optimized process or excipients to maintain the physical and chemical stability of the protein).
CD Formulation masters the most advanced spray-drying technology and can fully design and develop powerful protein/peptide spray-dried powders. These solid-state formulations can significantly improve the stability of your protein/peptide products and enable alternative routes of administration.
Fig.1 Requirements for successful spray dried biologic formulations. (Donthi MR, et al., 2023)
We comprehensively take into account the unique requirements of your target products and intentionally design these powders/particles to develop advanced downstream drug delivery systems, including inhalable powders, injectable suspensions, and long-acting implants. In addition, our experienced team of scientists can also apply nano spray dryers to prepare nano-scale protein/peptide spray-dried powders for targeted delivery.
Our scientists combine expertise in formulation and process development with proven capabilities in spray drying to provide you with unparalleled protein/peptide spray-dried powder development services and support you in the following aspects.
CD Formulation is an expert in spray formulation and process development. Our deep scientific knowledge, formulation and dosage form experience, and technical expertise form the cornerstone of our leadership in protein/peptide spray drying formulations. Our scientists systematically and comprehensively deploy advanced technologies and process strategies to design innovative spray formulations to ensure the successful formulation of proteins and peptides.
Fig.2 Schematic representation of spray drying process flow. (Donthi MR, et al., 2023)
Fig.3 Characterization of protein/peptide spray drying microparticle/nanoparticle.(CD Formulation)
Published Data
Technology: Ultrasonic spray-freeze-drying (USFD) technique for preparing dry powder inhaler formulations.
Journal: Int J Pharm.
IF: 5.8
Published: 2020
Results:
The authors successfully designed and prepared a dry powder inhalation formulation of ciprofloxacin and colistin co-loaded liposomes by ultrasonic spray freeze drying (USFD) technology, optimizing and characterizing the liposome formulation and powder production parameters to achieve optimal properties and in vitro performance, such as encapsulation efficiency (EE), particle size, particle size distribution index (PDI), fine particle fraction (FPF), emitted dose (ED), etc. The results showed that the formulation with mannitol (5% w/v) as the internal lyoprotectant and sucrose (5%, w/v), mannitol (10%, w/v), and leucine (5%, w/w) as the external lyoprotectants/aerosolization accelerators had the best rehydration EE values for ciprofloxacin and colistin (44.9±0.9% and 47.0±0.6%, respectively), good aerosol performance, and the liposome material was non-cytotoxic, which could be safely used for pulmonary drug delivery.
Fig. 4 Schematic diagram of the apparatus and the process for ultrasonic spray-freeze-drying. (Yu S, et al., 2020)
CD Formulation is at the forefront of protein and peptide formulation development, dedicated to providing unparalleled protein/peptide spray drying formulation development services to the pharmaceutical industry. Our formulation scientists combine state-of-the-art spray drying technology with the latest knowledge of protein and peptide science to create formulations that optimize stability, appearance, and manufacturability. Please feel free to contact us if you are interested in our services. We will provide you with the best solutions and support.
References